Method of isolating and detecting cancer stem cells
AssigneeCarcidiag Biotechnologies
InventorsVincent CARRE, Aurélie LACROIX
Life of this patent
Estimating the term…
Loading patent…
AssigneeCarcidiag Biotechnologies
InventorsVincent CARRE, Aurélie LACROIX
Estimating the term…
Disclosed is the in vitro use of at least one lectin which recognises the fucose alpha(1-2) galactose unit for labelling cancer stem cells of organs involved in respiration, in order to obtain labelled cancer stem cells of organs involved in respiration, in a biological sample. In one particular embodiment, the at least one lectin is chosen from the lectins Ulex Europaeus agglutinin 1 (UEA-1) or the homologue thereof, Trichosanthes japonica agglutinin II (TJA-II), Agaricus Bisporus agglutinin (ABA), Amaranthus Caudatus agglutinin (ACA), jacalin, Griffonia Simplicifolia lectin I (GSL-I) and Griffonia Simplicifolia lectin II (GSL-II). In one particular embodiment, the organ involved in respiration is chosen from the lungs, the larynx, the pharynx, the mouth, the nose, the throat, the tongue, the sinuses, the trachea and the saliva glands including the tonsils and the parotid gland.
1-44. (canceled)
An in vitro method for isolating cancer stem cells of organs involved in respiration in a biological sample comprising:
Method for in vitro diagnosis of the risk of recurrence of cancer of an organ involved in respiration and/or of the aggressiveness of cancer of an organ involved in respiration to define a prognostic value for the therapeutic adaptation of a cancer of an organ involved in respiration, comprising a step of labelling the cancer stem cells of organs involved in the respiration of a biological sample of organs involved in respiration with at least one lectin recognizing the fucose α 1-2 galactose unit, to obtain cancer stem cells of organs involved in respiration labelled by at least one lectin in said sample.
An in vitro kit for the diagnosis of the risk of recurrence of cancer of an organ involved in respiration and/or of the aggressiveness of cancer of an organ involved in respiration to define a prognostic value for the therapeutic adaptation of a cancer of an organ involved in respiration,
Dependencies are inferred from the claim text.